Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Medicine, Refractory (planetary science), Internal medicine, Lymphoma, Toxicity, Cytokine release syndrome, Gastroenterology, Diffuse large B-cell lymphoma, Progressive disease, Surgery, Neutropenia, Chemotherapy, Cancer, Immunotherapy, Chimeric antigen receptor